Immobilizing enzymes can expand their applicability to continuous process operations and facilitates process intensification. An optimized formulation of immobilized biocatalysts is therefore of strategic interest in the field of industrial biotechnology. Nevertheless, biocatalyst formulation still largely relies on empirical approaches which lack effectiveness in the identification of optimum immobilization conditions. In the present study, design of experiments, multiple linear regressions and modeling were used to screen, interpret and finally optimize crucial immobilization parameters. A laccase preparation from Coriolopsis polyzona MUCL38443 was immobilized via a sequential adsorption-crosslinking process on mesoporous silica particles. As a target variable, biocatalyst activity was doubled (∼280 U g(-1)) while dramatically reducing processing time (two hours instead of 26 hours) and reagent inputs (80 mm instead of 1m glutaraldehyde (GLU)). Immobilization yield (∼50%) and thermostability (∼60% residual activity after 24 hours at 45°C) could be maintained under the optimized conditions. As an example of its application in environmental biotechnology, the optimized biocatalyst was implemented in a continuous stirred-tank membrane reactor (CSTMR) to continuously degrade the endocrine disruptor bisphenol A (BPA) in wastewater. A 90% removal of 50 μm BPA was achieved over 30 reactor volumes (hydraulic residence time (HRT) of 1.85 hours, 50 mL working volume).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.nbt.2012.05.023 | DOI Listing |
Nat Commun
December 2024
Department of Inorganic Chemistry, Fritz-Haber Institute of the Max Planck Society, Berlin, Germany.
Future carbon management strategies require storage in elemental form, achievable through a sequence of CO hydrogenation reactions. Hydrogen is recycled from molecular intermediates by dehydrogenation, and side product acetylene selectively hydrogenated to ethylene. Existing Pd alloy catalysts for gas purification underperform in concentrated feeds, necessitating novel concepts.
View Article and Find Full Text PDFBioengineering (Basel)
October 2024
Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstraße 65, 88397 Biberach an der Riß, Germany.
Mol Pharm
November 2024
Department of Drug Sciences, University of Pavia, V.le Taramelli 12, Pavia 27100, Italy.
Oral immunization offers a minimally invasive administration, inducing local and systemic immune responses and facilitating mass immunization without needle-related risks. However, the gastrointestinal environment poses challenges, compromising vaccine effectiveness through enzymatic degradation and poor absorption by Peyer's patches. Advances in nanoparticle and microparticle (NP/MP) technology protect vaccines from degradation and enhance targeted release.
View Article and Find Full Text PDFInt J Numer Method Biomed Eng
December 2024
Department of Mechanical Engineering, Polytechnique Montréal, Montreal, Quebec, Canada.
Eur J Pharm Sci
December 2024
Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, Graz 8010, Austria; University of Graz, Institute of Pharmaceutical Sciences, Pharmaceutical Technology & Biopharmacy, Universitätsplatz 1, Graz 8010, Austria. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!